Stago Group News

Stago enters into exclusive negotiations with ARCHIMED and La Caisse

PRESS RELEASE: December 11, 2025

The Stago Group, a global leader in diagnostics and a specialist in hemostasis, announced today that it has entered into exclusive negotiations with a consortium led by ARCHIMED, an investment fund dedicated to the healthcare sector, with a view to acquiring a majority stake in the group. La Caisse (formerly Caisse de dépôt et Placement du Québec) would invest alongside ARCHIMED as a minority investor.

Stago's 2025 CSR Report is online

The Stago Group’s commitment to sustainability takes a new step forward with the release of our latest CSR report. More comprehensive, concrete, and forward-looking, it reflects the collective efforts of our international teams and subsidiaries, and the growing integration of CSR into our daily actions and long-term vision.

New Focus on Extracellular Vesicles

This Focus leaflet illustrates how extracellular vesicles (EVs), once confined to basic research, are now on the path to becoming valuable tools in clinical diagnostics. This last issue has been coordinated by Professor Françoise Dignat-George, recipient of the ISTH Esteemed Career Award 2025.

New Practical Manual on Hemostasis and Thrombosis in special patient populations

This new book is dedicated to the challenges of hemostasis and thrombosis in special patient populations, offering practical guidance for interpreting test results and improving patient care.

Stago at the 33rd Annual Congress of the ISTH in Washington, DC

The 33^rd Annual Congress of the ISTH (International Society on Thrombosis and Hemostasis) was held in Washington, DC, bringing together thousands of hemostasis specialists from around the world.